1. Home
  2. ITOS vs RLGT Comparison

ITOS vs RLGT Comparison

Compare ITOS & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • RLGT
  • Stock Information
  • Founded
  • ITOS 2011
  • RLGT 2001
  • Country
  • ITOS United States
  • RLGT United States
  • Employees
  • ITOS N/A
  • RLGT N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • RLGT Oil Refining/Marketing
  • Sector
  • ITOS Health Care
  • RLGT Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • RLGT Nasdaq
  • Market Cap
  • ITOS 270.7M
  • RLGT 295.7M
  • IPO Year
  • ITOS 2020
  • RLGT N/A
  • Fundamental
  • Price
  • ITOS $7.35
  • RLGT $5.97
  • Analyst Decision
  • ITOS Strong Buy
  • RLGT
  • Analyst Count
  • ITOS 3
  • RLGT 0
  • Target Price
  • ITOS $26.00
  • RLGT N/A
  • AVG Volume (30 Days)
  • ITOS 489.4K
  • RLGT 228.2K
  • Earning Date
  • ITOS 05-09-2025
  • RLGT 05-08-2025
  • Dividend Yield
  • ITOS N/A
  • RLGT N/A
  • EPS Growth
  • ITOS N/A
  • RLGT 32.26
  • EPS
  • ITOS N/A
  • RLGT 0.29
  • Revenue
  • ITOS $35,000,000.00
  • RLGT $858,699,000.00
  • Revenue This Year
  • ITOS N/A
  • RLGT $12.86
  • Revenue Next Year
  • ITOS $31.74
  • RLGT $5.75
  • P/E Ratio
  • ITOS N/A
  • RLGT $20.50
  • Revenue Growth
  • ITOS 177.89
  • RLGT N/A
  • 52 Week Low
  • ITOS $4.80
  • RLGT $4.83
  • 52 Week High
  • ITOS $18.75
  • RLGT $7.94
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 62.54
  • RLGT 47.99
  • Support Level
  • ITOS $7.01
  • RLGT $5.61
  • Resistance Level
  • ITOS $7.56
  • RLGT $6.13
  • Average True Range (ATR)
  • ITOS 0.49
  • RLGT 0.25
  • MACD
  • ITOS 0.26
  • RLGT 0.05
  • Stochastic Oscillator
  • ITOS 92.39
  • RLGT 75.88

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

Share on Social Networks: